Cost Of GLP-1 Without Insurance: 2026 Full Price Guide

Last updated: April 15, 2026

Quick Answer: The cost of GLP-1 without insurance ranges from $149 to $1,349 per month in 2026, depending on the medication and whether you use a brand-name drug or a compounded alternative. Brand-name injectables like Ozempic and Wegovy run $935–$1,349/month, while compounded semaglutide from regulated pharmacies costs $200–$400/month, and the new Wegovy pill starts as low as $149/month. [1][2]

Detailed () infographic-style image showing a side-by-side price comparison chart of GLP-1 medications without insurance:

Table of Contents - [Open] ➨

Key Takeaways

Brand-name GLP-1 injectables cost $900–$1,349 per month without insurance, adding up to $10,800–$16,188 annually [1]
Compounded semaglutide from FDA-regulated 503B pharmacies costs $200–$400/month, saving up to 70% vs. brand-name pricing [1]
The new Wegovy pill starts at $149/month for the 1.5 mg dose, making it the most affordable branded GLP-1 option in 2026 [2]
Manufacturer savings programs can cut costs to $25–$200/month for eligible patients with commercial insurance [1]
Medicare Part D coverage for GLP-1s is expanding in 2026, with a bridge program offering $245/month pricing starting July 2026 [4]
Telehealth platforms often offer the lowest prices for compounded GLP-1s, sometimes as low as $99–$199/month [2]
Tirzepatide medications (Mounjaro, Zepbound) cost $1,023–$1,349/month uninsured, but manufacturer programs reduce Zepbound to $299–$449/month [3]
If insurance denies your claim, you have options — including appeals, savings cards, and compounded alternatives

What Is the Actual Cost of GLP-1 Without Insurance in 2026?

The cost of GLP-1 without insurance in 2026 varies widely based on the drug, the form (injectable vs. pill), and where you get it. Brand-name options are expensive, but affordable alternatives exist if you know where to look.

Here’s a clear breakdown of current pricing:

Medication	Type	Monthly Cost (No Insurance)
Ozempic (semaglutide)	Injectable	$935–$1,200 [1]
Wegovy (semaglutide)	Injectable	$1,200–$1,349 [1]
Wegovy (semaglutide)	Pill (1.5–4 mg)	$149–$199 [2]
Wegovy (semaglutide)	Pill (9–25 mg)	$299 [2]
Mounjaro (tirzepatide)	Injectable	$1,023–$1,349 [1]
Zepbound (tirzepatide)	Injectable	$299–$449 (via Lilly program) [3]
Compounded semaglutide	Injectable	$200–$400 [1]
Compounded semaglutide	Flat-rate telehealth	$99–$199 [2]

Decision rule: If you’re paying full price with no assistance, compounded semaglutide or the new Wegovy pill are the most cost-effective starting points. If you have commercial insurance, always check manufacturer savings cards first.

For a deeper look at semaglutide-specific pricing, see this complete semaglutide cost breakdown for 2026.

Why Are Brand-Name GLP-1 Medications So Expensive Without Insurance?

Brand-name GLP-1 drugs are expensive because of research and development costs, patent protections, and limited competition. Without insurance negotiating on your behalf, you pay the full list price, which manufacturers set based on market positioning rather than production cost.

Ozempic and Wegovy are made by Novo Nordisk. Mounjaro and Zepbound come from Eli Lilly. Both companies have recently adjusted pricing in response to public pressure and policy changes.

What’s changing in 2026:

Novo Nordisk reduced Ozempic and Wegovy co-pay card pricing to $350/month (down from $499/month) for eligible patients [3]
Eli Lilly now offers Zepbound multi-dose pens at $299–$449/month through transitional programs (down from $349–$499/month) [3]
These reductions apply to specific programs, not automatically to all uninsured patients

Common mistake: Many people assume they can’t afford GLP-1s without insurance and give up without checking manufacturer programs. That’s leaving real money on the table.

Annual costs without any assistance can reach $10,800 to $16,188 depending on which medication you use [1]. That’s a number worth fighting to reduce.

Brand-Name vs. Compounded GLP-1: Which Costs Less Without Insurance?

Wide-angle () showing a split-scene comparison: left side depicts a pharmacy counter with a pharmacist handing over a

Compounded semaglutide costs significantly less than brand-name GLP-1 medications without insurance. The savings can reach 70% or more compared to Ozempic or Wegovy injectables. [1]

Brand-name GLP-1s (no insurance):

Ozempic: $935–$1,200/month
Wegovy injectable: $1,200–$1,349/month
Mounjaro: $1,023–$1,349/month

Compounded semaglutide options:

503B FDA-regulated pharmacy: $200–$400/month [1]
Telehealth flat-rate services: $99–$199/month [2]
Some services (like Kongo) offer semaglutide at a flat $99/month through NABP-accredited, LegitScript-verified U.S. pharmacies [2]

What is a 503B pharmacy? These are FDA-regulated outsourcing facilities that must meet strict safety and quality standards. They’re not the same as a random online pharmacy. Compounded medications from 503B facilities are a legitimate, regulated option — though they are not FDA-approved products in the same way brand-name drugs are.

Choose compounded if: You’re paying entirely out of pocket, you’ve been priced out of brand-name options, and you’re working with a licensed telehealth provider who can monitor your progress.

Choose brand-name if: You have commercial insurance with partial coverage, or you qualify for a manufacturer savings program that brings your cost below $200/month.

For a full comparison of your cheapest options, check out the most affordable GLP-1 medications without insurance.

What Savings Programs Exist for GLP-1 Costs Without Insurance?

Several manufacturer programs and third-party tools can significantly reduce GLP-1 costs, even without insurance. These aren’t well-advertised, but they’re real and worth pursuing.

Novo Nordisk programs (Ozempic and Wegovy):

NovoCare savings card: Reduces cost to $25–$200/month for patients with commercial insurance or specific income criteria [1]
Updated co-pay cards now cap monthly costs at $350/month for eligible uninsured patients [3]
Note: These typically exclude Medicare and Medicaid patients

Eli Lilly programs (Mounjaro and Zepbound):

Savings cards cap Mounjaro and Zepbound at $25–$150/month for commercially insured patients [1]
Transitional programs offer Zepbound at $299–$449/month for uninsured patients [3]
See our guide on the Mounjaro $25 coupon for uninsured patients to understand who actually qualifies

GoodRx and pharmacy discount programs:

GoodRx coupons can reduce Wegovy costs by up to 70% at participating pharmacies
Prices vary significantly between pharmacies — up to $200 difference for tirzepatide depending on location [1]
See GoodRx Wegovy coupons for uninsured patients for current discount codes

Step-by-step to find the lowest price:

Check the manufacturer’s official savings card (NovoCare or Lilly Cares)
Run your medication through GoodRx and compare at 3–5 local pharmacies
Ask your doctor about telehealth platforms with compounded semaglutide
If denied by insurance, consider filing an appeal (more on that below)

How Does Medicare and Medicaid Coverage Affect GLP-1 Costs?

Overhead flat-lay () showing a wooden desk with a Medicare card, insurance denial letter, savings coupon clipping, and a

Medicare and Medicaid coverage for GLP-1 medications is expanding significantly in 2026 and 2027. If you’re on Medicare, you may have access to lower pricing sooner than you think.

Medicare GLP-1 Bridge Program: Starting July 2026, eligible Medicare Part D beneficiaries can access GLP-1 drugs through a short-term demonstration program at a net price of $245 per monthly supply [4]. This is a major development for seniors who’ve been priced out entirely.

BALANCE Model expansion:

Medicaid access to GLP-1s for weight loss launches as early as May 2026 for participating states [4]
Full Medicare Part D access expands in January 2027 [4]
Eligible Medicare patients with a weight loss indication will pay a $50 copay [3]

Important caveat: Manufacturer savings cards (the $25–$150/month programs) typically exclude Medicare and Medicaid patients [1]. The new government programs are specifically designed to fill that gap.

If you’re on Medicare right now: Contact your Part D plan directly and ask about the GLP-1 Bridge Program. Coverage eligibility and enrollment details are available through CMS [4].

For patients whose insurance has denied coverage, our guide on how to appeal an insurance denial for semaglutide walks through the process step by step.

What Are the Cheapest Ways to Get GLP-1 Medications Without Insurance?

The cheapest ways to access GLP-1 medications without insurance in 2026 are telehealth platforms offering compounded semaglutide, the new Wegovy pill, and manufacturer transition programs for tirzepatide. Prices start as low as $99/month.

Ranked from lowest to highest monthly cost:

Telehealth flat-rate compounded semaglutide — $99–$199/month [2]
Wegovy pill (1.5 mg dose) — $149/month [2]
Wegovy pill (4 mg dose) — $199/month [2]
Compounded semaglutide (503B pharmacy) — $200–$400/month [1]
Wegovy pill (9–25 mg dose) — $299/month [2]
Zepbound via Lilly transitional program — $299–$449/month [3]
Ozempic with NovoCare savings — $350/month [3]
Brand-name Ozempic, full price — $935–$1,200/month [1]

Edge case to know: The Wegovy pill is a newer option and may not be appropriate for everyone. Dosing is different from the injectable, and your prescriber needs to assess which form is right for your situation.

For a side-by-side comparison of oral vs. injectable semaglutide costs, see semaglutide pills vs. injections cost comparison.

Also worth reviewing: the 7 cheapest GLP-1 options without insurance for a ranked breakdown with current pricing.

Is It Safe to Use Compounded GLP-1 Medications?

Compounded semaglutide from a licensed 503B facility can be a safe option when prescribed and monitored by a licensed healthcare provider. However, not all compounding pharmacies are equal, and the source matters significantly.

What makes a compounded GLP-1 safer:

Sourced from an FDA-regulated 503B outsourcing facility
Prescribed through a licensed telehealth provider or physician
Pharmacy is NABP-accredited and LegitScript-verified [2]
Regular follow-up and dosage monitoring included in the service

What to avoid:

Unverified online pharmacies with no licensing information
Services that don’t require a consultation or prescription
“Peptide” sellers marketing semaglutide as a research chemical

FDA status note: Compounded semaglutide is not an FDA-approved product. It’s prepared under FDA oversight (for 503B facilities) but is distinct from brand-name Ozempic or Wegovy. This is worth discussing with your doctor.

Side effects for compounded semaglutide are generally similar to the brand-name version: nausea, vomiting, and GI discomfort are the most common, especially when starting or increasing doses.

Frequently Asked Questions About GLP-1 Costs Without Insurance

Close-up () of an adult's hands holding a smartphone displaying a telehealth consultation screen with a GLP-1 prescription

How much does GLP-1 cost per month without insurance? Brand-name GLP-1 injectables cost $935–$1,349/month without insurance. Compounded semaglutide costs $200–$400/month, and the Wegovy pill starts at $149/month. [1][2]

What is the cheapest GLP-1 medication available in 2026? The cheapest options are telehealth-based compounded semaglutide at $99–$199/month and the Wegovy pill at $149/month for the starting dose. [2]

Can I get GLP-1 medications for $25/month? The $25/month savings cards from Novo Nordisk and Eli Lilly are primarily for patients with commercial insurance. Most uninsured patients do not qualify for the $25 tier. [1]

Does Medicare cover GLP-1 drugs for weight loss? Starting July 2026, eligible Medicare Part D beneficiaries can access GLP-1s through the Medicare GLP-1 Bridge Program at $245/month. Full Part D coverage for weight loss expands in January 2027. [4]

Is compounded semaglutide legal? Yes, compounded semaglutide from a licensed 503B pharmacy is legal when prescribed by a licensed provider. It is not FDA-approved as a finished product but is prepared under FDA oversight. [1]

What’s the difference between Ozempic and Wegovy costs? Ozempic (approved for type 2 diabetes) costs $935–$1,200/month uninsured. Wegovy (approved for weight loss) costs $1,200–$1,349/month for the injectable. The new Wegovy pill starts at $149/month. [1][2]

How do I get GLP-1 covered by insurance? You typically need a qualifying diagnosis (type 2 diabetes for Ozempic, obesity with BMI ≥30 or ≥27 with a comorbidity for Wegovy) and prior authorization. See our guide on how to get GLP-1 covered by insurance.

Are there state programs that help with GLP-1 costs? Yes. Several states are expanding Medicaid coverage for GLP-1s as part of the BALANCE Model starting May 2026. Coverage varies by state. [4][5]

What happens if my insurance denies my GLP-1 claim? You can file an appeal. Many denials are reversed with proper documentation from your doctor. The process typically takes 30–60 days.

Is tirzepatide cheaper than semaglutide without insurance? No. Tirzepatide-based drugs (Mounjaro, Zepbound) cost $1,023–$1,349/month uninsured, similar to or slightly higher than semaglutide injectables. [1]

Can I use GoodRx for GLP-1 medications? Yes. GoodRx can reduce costs at participating pharmacies. Savings vary, but discounts of 20–40% are common on some GLP-1 medications.

How do I find a telehealth provider for compounded semaglutide? Several licensed telehealth platforms connect patients with prescribers and partner with regulated compounding pharmacies. Look for services that require a consultation, use 503B pharmacies, and include ongoing monitoring.

Conclusion: What Should You Do Next?

The cost of GLP-1 without insurance is high — but it’s not a dead end. In 2026, you have more options than ever to access these medications at a fraction of the brand-name price.

Here’s what to do based on your situation:

No insurance, tight budget: Start with the Wegovy pill ($149/month) or a telehealth platform offering compounded semaglutide ($99–$199/month)
Commercial insurance that doesn’t cover GLP-1s: Check manufacturer savings cards from Novo Nordisk and Eli Lilly — you may qualify for $25–$350/month pricing
On Medicare: Ask your Part D plan about the GLP-1 Bridge Program starting July 2026 ($245/month net price)
Insurance denied your claim: File an appeal with your doctor’s support — many denials are overturned
Comparing tirzepatide vs. semaglutide: Both are similarly priced uninsured; your doctor should guide the clinical choice

Don’t let sticker shock stop you from exploring what’s actually available. The landscape has shifted significantly in 2026, and affordable paths to GLP-1 treatment exist for most people who look for them.

For a full comparison of your best options, start with the GLP-1s without insurance review for 2026 and the cheapest GLP-1 medications guide.